Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial

Triple-negative breast cancer (TNBC) is a highly heterogeneous disease, and molecular subtyping may result in improved diagnostic precision and targeted therapies. Our previous study classified TNBCs into four subtypes with putative therapeutic targets. Here, we conducted the FUTURE trial (ClinicalT...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cell Res
Main Authors: Jiang, Yi-Zhou, Liu, Yin, Xiao, Yi, Hu, Xin, Jiang, Lin, Zuo, Wen-Jia, Ma, Ding, Ding, Jiahan, Zhu, Xiaoyu, Zou, Jianjun, Verschraegen, Claire, Stover, Daniel G., Kaklamani, Virginia, Wang, Zhong-Hua, Shao, Zhi-Ming
格式: Artigo
語言:Inglês
出版: Springer Singapore 2020
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027015/
https://ncbi.nlm.nih.gov/pubmed/32719455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41422-020-0375-9
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍